8-K
Current Report
Celldex Therapeutics, Inc. Filed Acc 0001104659-18-026170
Exit or restructuring costs
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading a18-12122_18k.htm…